How has been the historical performance of Titan Biotech?
Titan Biotech's historical performance shows increasing net sales from INR 64.91 crore in March 2019 to INR 164.07 crore in March 2024, but profitability metrics have declined since peaking in March 2021, with net profit falling from INR 30.34 crore to INR 21.53 crore by March 2025. Total assets and liabilities have risen significantly, indicating growth in sales and assets despite decreasing profitability.
Answer:The historical performance of Titan Biotech shows a fluctuating trend in key financial metrics over the years.Breakdown:
Titan Biotech's net sales have seen a gradual increase from INR 64.91 crore in March 2019 to INR 164.07 crore in March 2024, although there was a slight decline to INR 156.45 crore in March 2025. The total operating income followed a similar pattern, peaking at INR 164.07 crore in March 2024 before dropping to INR 156.45 crore in March 2025. The company's total expenditure, excluding depreciation, has risen from INR 56.05 crore in March 2019 to INR 131.02 crore in March 2025. Operating profit (PBDIT) has fluctuated, reaching a high of INR 46.92 crore in March 2021 but decreasing to INR 29.34 crore by March 2025. Profit before tax also peaked at INR 42.71 crore in March 2021, subsequently declining to INR 24.37 crore in March 2025. The profit after tax followed a similar trend, decreasing from INR 31.71 crore in March 2021 to INR 18.27 crore in March 2025. The consolidated net profit also showed a decline from INR 30.34 crore in March 2021 to INR 21.53 crore in March 2025. On the balance sheet, total liabilities increased from INR 64.73 crore in March 2019 to INR 156.58 crore in March 2024, while total assets rose from INR 64.73 crore to INR 156.58 crore in the same period. Cash flow from operating activities remained stable at INR 21 crore in March 2023 and March 2024, but the net cash outflow was recorded at INR 2 crore in March 2024. Overall, Titan Biotech has experienced growth in sales and assets, but profitability metrics have shown a downward trend in recent years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
